MIF and pancreatic neoplasm: The upregulation of macrophage migration inhibitory factor (MIF) may be an early event of cancer progression: in fact, markedly higher levels of this cytokine were detected from plasma exosomes of stage I PDAC patients who later developed liver metastasis compared with patients whose pancreatic tumor did not progress [38].